Syngen Biotech Co.,Ltd. (TPEX:8279)
Taiwan · Delayed Price · Currency is TWD 97.00
-0.90 (-0.92%)
Jun 18, 2026, 1:30 PM CST
Syngen Biotech Market Cap
Syngen Biotech has a market cap or net worth of 2.63 billion as of June 18, 2026. Its market cap has decreased by -30.96% in one year.
Market Cap
2.63B
Enterprise Value
2.47B
Revenue
2.07B
Ranking
n/a
PE Ratio
11.07
Stock Price
97.00
Market Cap Chart
Since November 2, 2004, Syngen Biotech's market cap has increased from 372.00M to 2.63B, an increase of 606.66%. That is a compound annual growth rate of 9.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 2.63B | -16.38% |
| Dec 31, 2025 | 3.14B | -8.66% |
| Dec 30, 2024 | 3.44B | -16.45% |
| Dec 29, 2023 | 4.12B | -6.17% |
| Dec 30, 2022 | 4.39B | 43.36% |
| Dec 30, 2021 | 3.06B | 4.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Energenesis Biomedical CO.,LTD. | 3.22B |
| Shine-On BioMedical | 3.15B |
| BioGend Therapeutics | 3.10B |
| BRIM Biotechnology | 2.98B |
| Apex Biotechnology | 2.93B |
| Genovate Biotechnology | 2.92B |
| GlycoNex Incorporation | 2.85B |
| Intech Biopharm | 2.74B |